• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Terveystalo

7.69 EUR+1.05 %9/7 17:29
12,254 following

TTALO

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Dividend
Investor consensus
Compare
+1.05 %
-1.41 %
-12.71 %
-21.77 %
-21.37 %
-35.16 %
-6.11 %
-33.36 %
-23.10 %

Terveystalo operates in the healthcare sector. The company offers services and solutions such as surveys and examinations, training and coaching, rehabilitation, and health and fitness mapping. Its customers include small and medium-sized corporate customers, as well as public sector players. The head office is located in Helsinki.

Read more
Market cap
976.91M EUR
Turnover
717K EUR
P/E (adj.) (26e)
10.84
EV/EBIT (adj.) (26e)
11.46
P/B (26e)
1.68
EV/S (26e)
1.26
Dividend yield-% (26e)
4.16 %
Coverage
Recommendation
Reduce
Target price
7.90 EUR
Updated
2026-06-08
Disclaimer
Roni Peuranheimo
Roni Peuranheimo

Analyst

Latest research

Latest analysis report

Released: 2026-06-09

Latest extensive report

Released: 2025-06-19

Revenue and EBIT-%
EPS and dividend
Financial calendar
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types

Forum discussions
Terveystalo’s CEO doesn’t understand anything about clinical reality and tries to cover up this ignorance by using plenty of foreign loanwords and surrounding themselves with commercially-oriented representatives who are just as clinically incompetent. Relations with the practitioners...
6/10/2026, 8:02 PM
16
In my opinion, it’s venturing heavily into the realm of groundless speculation if the entry of a single significant owner leads to considerations of a qualitative overhaul of the company’s management. Especially since we are not talking about a majority shareholder here. When Inderes...
6/25/2026, 4:33 PM
by JuhaR
11
Grow or die. Terveystalo is essentially operating as it should. Without taking a stance on the current management, doctors or priests should not lead anything related to business. Of course, their opinions can be consulted.
6/11/2026, 6:53 AM
by TitoK
11
These reflections on new diagnostics performed via the eyes are definitely not something for this decade; we’re talking more about this potentially happening in the 2030s or 2040s. It’s really not worth expecting Terveystalo to generate any euros from that perspective in the coming...
6/10/2026, 7:31 PM
by JNivala
11
Is it the case that Inderes is unable, unskilled, or afraid to evaluate management’s capabilities in its analyses? It seems so, as the companies themselves pay Inderes for this analytical work. It would be good to hear @inderes’s own perspective on this. In my opinion, this has a...
6/25/2026, 2:07 PM
by hulabaloo
10
Business professionals are required for that, not clinicians, so that aspect is on the right track; whether the right professionals were chosen is another matter. In Europe, it has long been common for even hospitals to be run by business people, and judging by the state of public...
6/12/2026, 5:41 AM
by Anderssonni
8
Doctors do the doctoring and managers do the leading. Wasn’t the core of this current strategy an integrated care pathway, which is now expanding towards eye health? In other words, adding more length and entry points to the care pathway.
6/12/2026, 2:30 PM
by Gadua Morhua
6
Read more on our forum
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
17/7
2026

Interim report Q2'26

7/10
2026

Half year dividend

21/10
2026

Interim report Q3'26

Press release2026-07-01 07:43

Terveystalo Half-Year 2026 result webcast and conference call on 17 July 2026

Terveystalo
Regulatory press release2026-06-30 14:40

Terveystalo Oyj: Terveystalo Plc's Extraordinary General Meeting has approved the proposed resolution related to the acquisition of Silmäasema Oy

Terveystalo
Regulatory press release2026-06-29 14:00

Change in Terveystalo’s Executive Team: Henri Mäenalanen to take up a new position outside the company

Terveystalo

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Terveystalo, Webcast, Q2'26
Webcast2026-07-17 09:30

Terveystalo, Webcast, Q2'26

Terveystalo
Regulatory press release2026-06-16 16:12

Terveystalo Plc increases bond maturing in 2028 by EUR 29.9 million and has submitted a listing application for the tap issue

Terveystalo
Terveystalo: Ytterligare styrka söks från optikverksamheten
Research2026-06-09 06:00 by
Roni Peuranheimo

Terveystalo: Ytterligare styrka söks från optikverksamheten

I och med förvärven av Silmäasema och Hohde rör sig Terveystalo från att vara en stabil utdelare mot en tydligare tillväxtinriktning.

Terveystalo
Terveystalo’s press conference on the Silmäasema acquisition
Webcast2026-06-08 11:00

Terveystalo’s press conference on the Silmäasema acquisition

A briefing for investors and analysts will be held on 8 June 2026 at 12:00 noon EEST.

Terveystalo
Terveystalo förvärvar Silmäasema och uppdaterar sin strategi
Analyst Comment2026-06-08 08:27 by
Roni Peuranheimo

Terveystalo förvärvar Silmäasema och uppdaterar sin strategi

Detta är ett transformativt företagsförvärv för Terveystalo.

Terveystalo
Regulatory press release2026-06-08 07:10

Terveystalo Oyj: Notice of Extraordinary General Meeting of Terveystalo Plc

Terveystalo
Regulatory press release2026-06-08 07:05

Inside information: Terveystalo to acquire Silmäasema to accelerate growth and increase presence in the growing eye care market

Terveystalo
Regulatory press release2026-06-08 07:00

Inside information: Terveystalo updates its strategic focus, financial targets for the medium term and dividend policy

Terveystalo
Terveystalo har avslutat förhandlingarna om nedskärningar
Analyst Comment2026-05-28 06:53 by
Roni Peuranheimo

Terveystalo har avslutat förhandlingarna om nedskärningar

Förhandlingar om nedskärningar leder till personalnedskärningar samt omfattande permitteringar.

Terveystalo
Terveystalo Q1'26: Historiskt svag efterfrågan tynger varje rad
Research2026-04-27 07:00 by
Roni Peuranheimo

Terveystalo Q1'26: Historiskt svag efterfrågan tynger varje rad

Terveystalos Q1-resultat var betydligt sämre än både våra och konsensus förväntningar, då efterfrågan på den privata hälsovårdsmarknaden var historiskt svag.

Terveystalo
Terveystalo, Webcast, Q1'26
Webcast2026-04-24 09:30

Terveystalo, Webcast, Q1'26

Terveystalo
Regulatory press release2026-04-24 08:00

Terveystalo Oyj: Terveystalo Group Interim Report January-March 2026: Despite the difficult demand environment, profitability remained at a good level

Terveystalo
Terveystalo inleder förhandlingar om nedskärningar på grund av svag efterfrågan
Analyst Comment2026-04-22 06:00 by
Roni Peuranheimo

Terveystalo inleder förhandlingar om nedskärningar på grund av svag efterfrågan

Behovet av minskningar signalerar att efterfrågan på hälsovårdstjänster inte kommer att återhämta sig inom den närmaste framtiden.

Terveystalo
Terveystalo Q1'26 förhandskommentar: Efterfrågeutsikterna är utmanande
Research2026-04-17 07:00 by
Roni Peuranheimo

Terveystalo Q1'26 förhandskommentar: Efterfrågeutsikterna är utmanande

Efterfrågemiljön på den privata hälsovårdsmarknaden har varit svag under början av året, baserat på flera offentliga datapunkter.

Terveystalo
Analyst Comment2026-04-01 07:14 by
Roni Peuranheimo

Mehiläinen fortsatte sin starka förvärvsdrivna tillväxt under 2025

Mehiläinen accelererade sin tillväxt markant förra året, men främst icke-organiskt.

TerveystaloPihlajalinna
Regulatory press release2026-03-31 08:00

Terveystalo Oyj: Changes in Terveystalo's Executive Team

Terveystalo
Regulatory press release2026-03-24 13:00

Terveystalo Oyj: Resolutions of the organising meeting of Terveystalo's Board of Directors

Terveystalo